Global Nanotechnology-Based Medical Devices Market – Analysis and Forecast (2021-2027)

Industry Insights by Product (Active Implantable Devices, Medical Textiles, and Wound Dressings, Biochips, Implantable Materials, and Others), and by Application (Therapeutic Applications, Research Applications, and Diagnostic Applications)

Industry Overview

The nanotechnology-based medical devices market was valued at USD 1.90 billion in 2020 and is anticipated to reach USD 20.15 billion in 2027, registering a CAGR of 36.3% during the forecast period 2021-2027. The nanotechnology-based medical device helps in medical diagnosis, prevention of disease, and treatment. Nanotechnology in medicine devices includes the use of nano-robots to create repairs at the cellular level and treat and detect damage to the human body. The global nanotechnology-based medical devices market is growing at a significant rate, due to expanding geriatric population and increasing government initiatives.

Different products such as biochips, active implantable devices, and medical textile and wound dressings contributed to the nanotechnology-based medical devices market size. The market has witnessed high demand for active implantable devices over the last few years due to mounting out-of-pocket healthcare expenditure, escalating occurrence of age-related and lifestyle associated disorders such as cardiovascular diseases and hearing diseases, and accessibility of insurance coverage and reimbursement for medical procedures.

Market Segmentation

Insight by Product

On the basis of product, the market is subdivided into active implantable devices, medical textiles, and wound dressings, biochips, implantable materials, and others. Of all product, active implantable devices segment anticipated the largest share in the market due to the increasing out-of-pocket healthcare expenditure, the existence of well-structured delivery channels, escalating occurrence of age-related and lifestyle associated disorders such as cardiovascular diseases, and accessibility of insurance coverage and reimbursement for medical procedures.

The implantable material segment is further subdivided into bone substitute materials and dental restorative materials. Moreover, the biochip segment is further subdivided into Lab-On-Chip, and DNA microarrays. In addition, the active implantable devices segment is further subdivided into hearing aid devices, retinal implants, and cardiac rhythm management devices.

Insight by Application

On the basis of application, the market is subdivided into therapeutic applications, research applications, and diagnostic applications.

Global Nanotechnology-Based Medical Devices Market Report Coverage

Industry Dynamics

Growth Drivers

The increasing government support, escalating occurrence of age-related and lifestyle associated disorders such as cardiovascular diseases and hearing diseases, large-scale development in nanotechnology, the existence of well-structured delivery channels, and expanding geriatric population are the primary growth drivers for nanotechnology-based medical devices market. For instance, according to the World Health Organization (WHO), globally in 2010 approximately 524 million people were aged 65 years and older and is expected to reach 1.5 billion in 2050.

Abundant mid-to-late stage product pipeline, escalating awareness about preventive measures in healthcare, accessibility of insurance coverage and reimbursement for medical procedures, mounting healthcare expenditure, advancement in technology, and huge growth opportunities in emerging markets are also facilitating the growth for the nanotechnology-based medical devices market.

Challenges

Strict and time-consuming product approval processes, insufficient standards and absence of regulatory approval frameworks, and elevated cost of medical devices are the major challenges for the growth of nanotechnology-based medical devices market.

Industry Ecosystem

Globally, the manufacturing companies trying to enter the nanotechnology-based medical devices market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier to the entry of new players. This offers an edge to the established players in the industry competition.

Geographic Overview

Geographically, North America is the largest nanotechnology-based medical devices market as in the region the geriatric population is increasing. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050. Escalating healthcare expenditure, numerous nanotechnology development programs introduced by the government, extremely developed healthcare system, mounting occurrence of chronic diseases such as cardiovascular diseases, and the existence of an enormous number of nanotechnology-based medical device manufacturing companies are also up surging growth of the North American nanotechnology-based medical devices market. For instance, according to according to Centers of Disease Control and Prevention (CDC), in the U.S. approximately 610,000 people die every year due to heart disease.

Asia-Pacific is observed to witness the fastest growth in the market, as the region comprises a large population base. In addition, expanding the geriatric population, escalating healthcare expenditure, mounting R&D expenditure in nanotechnology, the mounting occurrence of chronic and lifestyle associated disorders such as cardiovascular diseases, refining healthcare infrastructure, and escalating international research collaboration is also creating a positive impact on the nanotechnology-based medical devices market growth in the region.

Competitive Insight

Key players in the nanotechnology-based medical devices market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In October 2018, Stryker acquired HyperBranch Medical Technology, Inc, to improve its cranial closure portfolio and strengthens its position in neurotechnology business. 3M Company, AAP Implantate AG, Smith & Nephew PLC, Dentsply Sirona Inc., Perkinelmer, Inc., Stryker Corporation, Mitsui Chemicals, Inc., and Starkey Hearing Technologies are the key players offering nanotechnology-based medical devices.

The Nanotechnology-Based Medical Devices Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2021–2027.

Segments Covered in the Report

• By Product
  • Active Implantable Devices
  • Medical Textiles, and Wound Dressings
  • Biochips
  • Implantable Materials
  • Others
• By Application
  • Therapeutic Applications
  • Research Applications
  • Diagnostic Applications

Region Covered in the Report

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

Source: VynZ Research

1.    Research Overview

        1.1.    The Report Offers
        1.2.    Market Coverage
                1.2.1.    By Product
                1.2.2.    By Application                                
                1.2.3.    By Region
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Market Methodology
                1.5.1.    Data Sources
                        1.5.1.1. Primary Research
                        1.5.1.2. Secondary Research
                1.5.2.    Methodology
                        1.5.2.1. Data Exploration
                        1.5.2.2. Forecast Parameters
                        1.5.2.3. Data Validation
                        1.5.2.4. Assumptions
                1.5.3.    Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

        3.1.    Industry Dynamics
                3.1.1.    Market Growth Drivers
                3.1.2.    Market Restraints
                3.1.3.    Key Market Trends
                3.1.4.    Major Opportunities
        3.2.    Industry Ecosystem
                3.2.1.    Porter’s Five Forces Analysis
                3.2.2.    Recent Development Analysis
                3.2.3.    Value Chain Analysis
        3.3.    Competitive Insight
                3.3.1.    Competitive Position of Industry Players
                3.3.2.    Market Attractive Analysis
                3.3.3.    Market Share Analysis

4.    Global Market Estimate and Forecast

        4.1.    Global Market Overview
        4.2.    Global Market Estimate and Forecast to 2027

5.    Market Segmentation Estimate and Forecast

        5.1.    By Product
                5.1.1.    Active Implantable Devices
                        5.1.1.1. Market Definition
                        5.1.1.2. Market Estimation and Forecast to 2027  
                5.1.2.    Medical Textiles, and Wound Dressings
                        5.1.2.1. Market Definition
                        5.1.2.2. Market Estimation and Forecast to 2027
                5.1.3.    Biochips
                        5.1.3.1. Market Definition
                        5.1.3.2. Market Estimation and Forecast to 2027
                5.1.4.    Implantable Materials
                        5.1.4.1. Market Definition
                        5.1.4.2. Market Estimation and Forecast to 2027
                5.1.5.    Others
                        5.1.5.1. Market Definition
                        5.1.5.2. Market Estimation and Forecast to 2027        
        5.2.    By Application
                5.2.1.    Therapeutic Applications
                        5.2.1.1. Market Definition
                        5.2.1.2. Market Estimation and Forecast to 2027
                5.2.2.    Research Applications
                        5.2.2.1. Market Definition
                        5.2.2.2. Market Estimation and Forecast to 2027
                5.2.3.    Diagnostic Applications
                        5.2.3.1. Market Definition
                        5.2.3.2. Market Estimation and Forecast to 2027       
        
6.    North America Market Estimate and Forecast

        6.1.    By Product
        6.2.    By Application                
        6.3.    By Country
                6.3.1.    U.S. Market Estimate and Forecast
                6.3.2.    Canada Market Estimate and Forecast
                6.3.3.    Mexico Market Estimate and Forecast

7.    Europe Market Estimate and Forecast

        7.1.    By Product
        7.2.    By Application                
        7.3.    By Country
                7.3.1.    Germany Market Estimate and Forecast
                7.3.2.    France Market Estimate and Forecast
                7.3.3.    U.K. Market Estimate and Forecast
                7.3.4.    Italy Market Estimate and Forecast
                7.3.5.    Spain Market Estimate and Forecast
                7.3.6.    Rest of Europe Market Estimate and Forecast

8.    Asia-Pacific Market Estimate and Forecast

        8.1.    By Product
        8.2.    By Application                
        8.3.    By Country
                8.3.1.    China Market Estimate and Forecast
                8.3.2.    Japan Market Estimate and Forecast
                8.3.3.    India Market Estimate and Forecast
                8.3.4.    South Korea Market Estimate and Forecast
                8.3.5.    Singapore Market Estimate and Forecast
                8.3.6.    Rest of Asia-Pacific Market Estimate and Forecast

9.    Rest of the World (RoW) Market Estimate and Forecast

        9.1.    By Product
        9.2.    By Application                 
        9.3.    By Country
                9.3.1.    Brazil Market Estimate and Forecast
                9.3.2.    Saudi Arabia Market Estimate and Forecast
                9.3.3.    South Africa Market Estimate and Forecast
                9.3.4.    Other Countries Market Estimate and Forecast

10.    Company Profiles

        10.1.    3M Company
                10.1.1.    Snapshot
                10.1.2.    Overview
                10.1.3.    Offerings
                10.1.4.    Financial Insight
                10.1.5.    Recent Developments
        10.2.    AAP Implantate AG
                10.2.1.    Snapshot
                10.2.2.    Overview
                10.2.3.    Offerings
                10.2.4.    Financial Insight
                10.2.5.    Recent Developments
        10.3.    Smith & Nephew PLC
                10.3.1.    Snapshot
                10.3.2.    Overview
                10.3.3.    Offerings
                10.3.4.    Financial Insight
                10.3.5.    Recent Developments
        10.4.    Dentsply Sirona Inc.
                10.4.1.    Snapshot
                10.4.2.    Overview
                10.4.3.    Offerings
                10.4.4.    Financial Insight
                10.4.5.    Recent Developments
        10.5.    Perkinelmer Inc.
                10.5.1.    Snapshot
                10.5.2.    Overview
                10.5.3.    Offerings
                10.5.4.    Financial Insight
                10.5.5.    Recent Developments
        10.6.    Stryker Corporation
                10.6.1.    Snapshot
                10.6.2.    Overview
                10.6.3.    Offerings
                10.6.4.    Financial Insight
                10.6.5.    Recent Developments
        10.7.    Mitsui Chemicals Inc.
                10.7.1.    Snapshot
                10.7.2.    Overview
                10.7.3.    Offerings
                10.7.4.    Financial Insight
                10.7.5.    Recent Developments
        10.8.    Starkey Hearing Technologies
                10.8.1.    Snapshot
                10.8.2.    Overview
                10.8.3.    Offerings
                10.8.4.    Financial Insight
                10.8.5.    Recent Developments        

11.    Appendix

        11.1.    Exchange Rates
        11.2.    Abbreviations

Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.

List of Tables

Table 1 Sources
Table 2 Study Periods
Table 3 Data Reporting Unit
Table 4 Global Nanotechnology-Based Medical Devices Market, By Product, 2015-2020 (USD Million)
Table 5 Global Nanotechnology-Based Medical Devices Market, By Product, 2021–2027 (USD Million)
Table 6 Global Nanotechnology-Based Medical Devices Market, By Application, 2015-2020 (USD Million)
Table 7 Global Nanotechnology-Based Medical Devices Market, By Application, 2021–2027 (USD Million)
Table 8 Global Nanotechnology-Based Medical Devices Market, by Region, 2015-2020 (USD Million)
Table 9 Global Nanotechnology-Based Medical Devices Market, by Region, 2021–2027 (USD Million)
Table 10 North America Nanotechnology-Based Medical Devices Market, By Product, 2015-2020 (USD Million)
Table 11 North America Nanotechnology-Based Medical Devices Market, By Product, 2021–2027 (USD Million)
Table 12 North America Nanotechnology-Based Medical Devices Market, By Application, 2015-2020 (USD Million)
Table 13 North America Nanotechnology-Based Medical Devices Market, By Application, 2021–2027 (USD Million)
Table 14 North America Nanotechnology-Based Medical Devices Market, by Region, 2015-2020 (USD Million)
Table 15 North America Nanotechnology-Based Medical Devices Market, by Region, 2021–2027 (USD Million)
Table 16 Europe Nanotechnology-Based Medical Devices Market, By Product, 2015-2020 (USD Million)
Table 17 Europe Nanotechnology-Based Medical Devices Market, By Product, 2021–2027 (USD Million)
Table 18 Europe Nanotechnology-Based Medical Devices Market, By Application, 2015-2020 (USD Million)
Table 19 Europe Nanotechnology-Based Medical Devices Market, By Application, 2021–2027 (USD Million)
Table 20 Europe Nanotechnology-Based Medical Devices Market, by Region, 2015-2020 (USD Million)
Table 21 Europe Nanotechnology-Based Medical Devices Market, by Region, 2021–2027 (USD Million)
Table 22 Asia-Pacific Nanotechnology-Based Medical Devices Market, By Product, 2015-2020 (USD Million)
Table 23 Asia-Pacific Nanotechnology-Based Medical Devices Market, By Product, 2021–2027 (USD Million)
Table 24 Asia-Pacific Nanotechnology-Based Medical Devices Market, By Application, 2015-2020 (USD Million)
Table 25 Asia-Pacific Nanotechnology-Based Medical Devices Market, By Application, 2021–2027 (USD Million)
Table 26 Asia-Pacific Nanotechnology-Based Medical Devices Market, by Region, 2015-2020 (USD Million)
Table 27 Asia-Pacific Nanotechnology-Based Medical Devices Market, by Region, 2021–2027 (USD Million)
Table 28 RoW Nanotechnology-Based Medical Devices Market, By Product, 2015-2020 (USD Million)
Table 29 RoW Nanotechnology-Based Medical Devices Market, By Product, 2021–2027 (USD Million)
Table 30 RoW Nanotechnology-Based Medical Devices Market, By Application, 2015-2020 (USD Million)
Table 31 RoW Nanotechnology-Based Medical Devices Market, By Application, 2021–2027 (USD Million)
Table 32 RoW Nanotechnology-Based Medical Devices Market, by Region, 2015-2020 (USD Million)
Table 33 RoW Nanotechnology-Based Medical Devices Market, by Region, 2021–2027 (USD Million)
Table 34 Snapshot – 3M Company
Table 35 Snapshot – AAP Implantate AG
Table 36 Snapshot – Smith & Nephew PLC
Table 37 Snapshot – Dentsply Sirona Inc.
Table 38 Snapshot – Perkinelmer Inc.
Table 39 Snapshot – Stryker Corporation
Table 40 Snapshot – Mitsui Chemicals Inc.
Table 41 Snapshot – Starkey Hearing Technologies

List of Figures

Figure 1 Market Coverage
Figure 2 Research Phases
Figure 3 Secondary Sources for Different Parameters
Figure 4 Methodology
Figure 5 Data Mining & Exploration
Figure 6 Data Triangulation
Figure 7 Assumptions for Market Estimation and Forecast
Figure 8 Market Synopsis
Figure 9 Global Nanotechnology-Based Medical Devices Market- Growth Drivers and Restraints
Figure 10 Competitive Benchmark
Figure 11 Global Nanotechnology-Based Medical Devices Market Highlight
Figure 12 Global Nanotechnology-Based Medical Devices Market, By Product, 2015–2027 (USD Million)
Figure 13 Global Nanotechnology-Based Medical Devices Market, By Application, 2015–2027 (USD Million)
Figure 14 Global Nanotechnology-Based Medical Devices Market, by Region, 2015–2027 (USD Million)
Figure 15 North America Nanotechnology-Based Medical Devices Market Highlight
Figure 16 North America Nanotechnology-Based Medical Devices Market, By Product, 2015–2027 (USD Million)
Figure 17 North America Nanotechnology-Based Medical Devices Market, By Application, 2015–2027 (USD Million)
Figure 18 North America Nanotechnology-Based Medical Devices Market, by Region, 2015–2027 (USD Million)
Figure 19 Europe Nanotechnology-Based Medical Devices Market Highlight
Figure 20 Europe Nanotechnology-Based Medical Devices Market, By Product, 2015–2027 (USD Million)
Figure 21 Europe Nanotechnology-Based Medical Devices Market, By Application, 2015–2027 (USD Million)
Figure 22 Europe Nanotechnology-Based Medical Devices Market, by Region, 2015–2027 (USD Million)
Figure 23 Asia-Pacific Nanotechnology-Based Medical Devices Market Highlight
Figure 24 Asia-Pacific Nanotechnology-Based Medical Devices Market, By Product, 2015–2027 (USD Million)
Figure 25 Asia-Pacific Nanotechnology-Based Medical Devices Market, By Application, 2015–2027 (USD Million)
Figure 26 Asia-Pacific Nanotechnology-Based Medical Devices Market, by Region, 2015–2027 (USD Million)
Figure 27 RoW Nanotechnology-Based Medical Devices Market Highlight
Figure 28 RoW Nanotechnology-Based Medical Devices Market, By Product, 2015–2027 (USD Million)
Figure 29 RoW Nanotechnology-Based Medical Devices Market, By Application, 2015–2027 (USD Million)
Figure 30 RoW Nanotechnology-Based Medical Devices Market, by Region, 2015–2027 (USD Million)